UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(d)(4)
OF THE SECURITIES EXCHANGE ACT OF 1934
------------
USANA HEALTH SCIENCES, INC.
(Name of Subject Company)
USANA HEALTH SCIENCES, INC
(Name of Person(s) Filing Statement)
------------
Common Stock, $0.001 par value
(Title of Class of Securities)
------------
90328M107
(CUSIP Number of Class of Securities)
------------
Gilbert A. Fuller
Executive Vice President and Chief Financial Officer
USANA Health Sciences, Inc.
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
Telephone: (801) 954-7100
(Name, Address and Telephone Number of
Person Authorized to Receive Notices and
Communications on Behalf of the Person(s) Filing Statement)
With a copy to:
Robert M. Mattson, Jr.
Morrison & Foerster LLP
425 Market Street
San Francisco, CA 94105-2482
(415) 268-7000
|X| Check the box if the filing relates solely to preliminary communications
made before the commencement of a tender offer.
On May 20, 2008, USANA Health Sciences, Inc. (the "Company") issued a press
release announcing that its Board of Directors has formed a Special Committee of
independent directors to evaluate and respond to any offer received from Gull
Holdings, Ltd. and the other tender offer participants to acquire all of the
outstanding shares of the Company that Gull Holdings and the other tender offer
participants do not already own, as announced in Schedule TO under Section 14d-1
or Section 13(e)(1), filed with the Securities and Exchange Commission by Gull
Holdings and the other tender offer participants on May 13, 2008. A copy of the
Company's press release is attached as Exhibit 99.1 to this Schedule 14D-9.
Exhibit No. Description
99.1 Press release dated May 20, 2008.
2